About Oneiro Chemicals
Oneiro Chemicals is a company based in Vadodara (India) founded in 2004 by Pranav Dushyant Patel. Oneiro Chemicals has raised $253.68 thousand across 1 funding round from investors including Transpekfinance. The company has 405 employees as of April 09, 2024. Oneiro Chemicals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Vadodara, India
- Employees 405 as on 09 Apr, 2024
- Founders Pranav Dushyant Patel
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oneiro Lifecare Private Limited
- Date of Incorporation 27 Oct, 2004
- Jurisdiction Vadodara, Gujarat, India
-
Annual Revenue
$28.98 M (USD)5.11as on Mar 31, 2023
-
Net Profit
$1.87 M (USD)-36.13as on Mar 31, 2023
-
EBITDA
$2.73 M (USD)-35.23as on Mar 31, 2023
-
Total Equity Funding
$253.68 K (USD)
in 1 rounds
-
Latest Funding Round
$253.68 K (USD), Seed
Jan 01, 2008
- Investors
-
Employee Count
405
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oneiro Chemicals
Oneiro Chemicals has successfully raised a total of $253.68K through 1 strategic funding round. The most recent funding activity was a Seed round of $253.68 thousand completed in January 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oneiro Chemicals
Oneiro Chemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Transpekfinance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Oneiro Chemicals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oneiro Chemicals
Investment portfolio details for Oneiro Chemicals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oneiro Chemicals
Detailed financials for Oneiro Chemicals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oneiro Chemicals Comparisons
Peer comparison for Oneiro Chemicals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oneiro Chemicals
Oneiro Chemicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Oneiro Chemicals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oneiro Chemicals
Complete news archive for Oneiro Chemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oneiro Chemicals
Oneiro Chemicals was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Oneiro Chemicals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Oneiro Chemicals is a funded company, having raised a total of $253.68K across 1 funding round to date.
As of Apr 09, 2024, the latest employee count at Oneiro Chemicals is 405.
Annual revenue of Oneiro Chemicals is $28.98M as on Mar 31, 2023.
Oneiro Chemicals was established in 2004 in Vadodara, India, within the pharmaceutical sector. Active Pharmaceutical Ingredients including Dextromethorphan HBr, Omeprazole, Esomeprazole Mg-Trihydrate, Folic Acid, and Pregabalin are produced. Intermediates for Omeprazole, Dextromethorphan HBr, Carvedilol, Lamotrigine, and Quinoline Phosphate are also manufactured. Operations center on API and intermediate production for pharmaceutical applications.
Oneiro Chemicals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Oneiro Chemicals has 1 investor. Key investors include Transpekfinance.
The valuation of Oneiro Chemicals is $1.52M as of Jan 2008.